TVRD - Cara Therapeutics, Inc. Price to Sales

Corporate company logo of Cara Therapeutics, Inc. (TVRD)

Cara Therapeutics Inc (TVRD) operates in an aggressive environment where patent loss risks and pressure from industry behemoths create serious challenges. The company is currently radically cutting R&D expenses in an effort to preserve capital following trial failures. Simultaneously, the team attracts top biochemists through a flexible culture and stock options. This P/S chart illustrates the business valuation dynamics, where the value 15.10 describes the current level of the market multiple.

TVRD Cara Therapeutics Inc: P/S Multiple in the range 07/04/2022 - 05/09/2026

Analytical breakdowns for Cara Corp (TVRD)

- current quotes and average value forecast:
- market capitalization statistics:
Summary company analytics:Cara Pharma, TVRD
Finished products of Cara Pharma

The P/S ratio determines the market value of a business relative to its annual turnover, allowing an investor to assess the premium paid per unit of generated revenue. By analyzing the price-to-sales ratio of Cara Therapeutics Inc (TVRD), one can understand how the market values the potential of renal pruritus treatments developed in collaboration with Vifor Pharma, which confirms the company's fundamental stability.